共 43 条
- [31] Lipid profile with eslicarbazepine acetate and carbamazepine monotherapy in adult patients with newly diagnosed focal seizures: post hoc analysis of a phase III trial and open-label extension studyTHERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2023, 16Trinka, EugenRocamora, RodrigoChaves, JoaoKoepp, Mathias J.Rueegg, StephanHoltkamp, MartinMoreira, JoanaFonseca, Miguel M.Castilla-Fernandez, GuillermoIkedo, Fabio
- [32] Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON) (vol 102, 106655, 2020)EPILEPSY & BEHAVIOR, 2020, 104Abril Jaramillo, JavierEstevez Maria, Jose CarlosGiron Ubeda, Juan MiguelVega Lopez, OscarCalzado Rivas, Maria ElenaPerez Diaz, HernandoGarcia Martin, GuillerminaVila Herrero, ElenaChamorro Munoz, Maria IsabelVazquez Gutierrez, Fernandode la Fuente Canete, CristinaRedondo Verge, LuisPelaez Vina, NazaretSantagueda, PatriciaRodriguez Uranga, Juan Jesus
- [33] Long-term efficacy and safety of eslicarbazepine acetate: Results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsyEPILEPSIA, 2010, 51 (10) : 1963 - 1969Halasz, PeterCramer, Joyce A.Hodoba, DaniloCzlonkowska, AnnaGuekht, AllaMaia, JoanaElger, ChristianAlmeida, LuisSoares-da-Silva, Patricio
- [34] Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307EPILEPSIA, 2018, 59 (04) : 866 - 876Krauss, Gregory L.Perucca, EmilioKwan, PatrickBen-Menachem, ElinorWang, Xue-FengShih, Jerry J.Patten, AnnaYang, HaichenWilliams, BetsyLaurenza, Antonio
- [35] Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: Results of a 1-year open-label extension studyEPILEPSY RESEARCH, 2013, 103 (2-3) : 262 - 269Hufnagel, AndreasBen-Menachem, ElinorGabbai, Alberto A.Falcao, AmilcarAlmeida, LuisSoares-da-Silva, Patricio
- [36] Long-term safety and efficacy outcomes of adjunctive perampanel: an open-label extension (OLEx) of a Phase III study in patients with drug-resistant primary generalized tonic-clonic (PGTC) seizures in idiopathic generalized epilepsy (IGE)NEUROLOGY, 2017, 88Wechsler, Robert T.French, JacquelineTrinka, EugenBrandt, ChristianO'Brien, TerenceBibbiani, FrancescoPatten, AnnaLaurenza, Antonio
- [37] Long-Term Efficacy and Safety of Adjunctive Perampanel in Elderly Patients (Aged ≥60 Years) with Focal-Onset Seizures (FOS): Post Hoc Analysis of Open-Label Extension (OLEx) Studies by Enzyme-Inducing Anti-Seizure Medication (EIASM) UseANNALS OF NEUROLOGY, 2021, 90 : S110 - S111Marawar, RohitLeppik, Ilo E.Wechsler, Robert T.Patten, AnnaNgo, Leock Y.Malhotra, Manoj
- [38] The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial (vol 397, pg 1363, 2021)LANCET, 2021, 397 (10287): : 1808 - 1808Marson, A.Burnside, G.Appleton, R.
- [39] The SANAD II study of the effectiveness and costeffectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial (vol 397, pg 1375, 2021)LANCET, 2021, 397 (10284): : 1544 - 1544Marson, A.Burnside, G.Appleton, R.
- [40] Pharmacokinetics and safety of VALTOCO (NRL-1; diazepam nasal spray) in patients with epilepsy during seizure (ictal/peri-ictal) and nonseizure (interictal) conditions: a phase 1, open-label study (vol 61, pg 935, 2020)EPILEPSIA, 2021, 62 (04) : 1038 - 1038Hogan, R. E.Tarquinio, D.Sperling, M. R.Klein, P.Miller, ISegal, E. B.